This topic contains a solution. Click here to go to the answer

Author Question: Light enters a substance from air at an angle of 32.0, and continues at an angle of 23.0. What is ... (Read 134 times)

michelleunicorn

  • Hero Member
  • *****
  • Posts: 565
Light enters a substance from air at an angle of 32.0, and continues at an angle of 23.0. What is the index of refraction of the substance?
 
  A)
 
  0.74
  B)
 
  1.11
  C)
 
  1.28
  D)
 
  1.36
  E)
 
  1.52

Question 2

Light of wavelength 580 nm is incident on a slit of width 0.300 mm. An observing screen is placed 2.00 m from the slit. Find the width of the central maximum.
 
  A)
 
  0.26 mm
  B)
 
  1.9 mm
  C)
 
  3.9 mm
  D)
 
  4.3 mm
  E)
 
  7.7 mm



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcarey591

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

D

Answer to Question 2

E




michelleunicorn

  • Member
  • Posts: 565
Reply 2 on: Jul 29, 2018
Wow, this really help


bassamabas

  • Member
  • Posts: 294
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library